RecruitingNot applicableNCT05444348

Compassionate Communication and Advance Care Planning to Improve End of Life Care in Treatment of Hematological Disease (ACT)

Studying PLA2G6-associated neurodegeneration

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Christoffer Johansen
Principal Investigator
Christoffer Johansen, Professor
Rigshospitalet, Denmark
Intervention
Advance consultation concerning your life and treatment (ACT )(behavioral)
Enrollment
920 enrolled
Eligibility
18 years · All sexes
Timeline
20222026

Study locations (7)

Collaborators

Rigshospitalet, Denmark · Zealand University Hospital · Odense University Hospital · Vejle Hospital · Esbjerg Hospital - University Hospital of Southern Denmark · Gødstrup Hospital · Aarhus University Hospital · Aalborg University Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05444348 on ClinicalTrials.gov

Other trials for PLA2G6-associated neurodegeneration

Additional recruiting or active studies for the same condition.

See all trials for PLA2G6-associated neurodegeneration

← Back to all trials